
Asmaphylin M 231mg/69mg/10mg Tablet SR
Marketer
ICI Healthcare Pvt Ltd
Salt Composition
Etofylline (231mg) + Theophylline (69mg) + Montelukast (10mg)
Overview Asmaphylin M 231mg/69mg/10mg Tablet SR
BronchEase Triple Action tablets (231mg/69mg/10mg sustained-release) are a combined medication for asthma management. This formulation works by relaxing airway muscles, improving airflow and breathing ease. It also provides relief from associated allergic symptoms including nasal discharge, sneezing, throat discomfort, eye watering, and nasal congestion. BronchEase Triple Action tablets should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Your individual dose will be tailored to your response and condition. Continue the medication as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your physician of all other medications you are currently using, as interactions are possible. Common side effects may include skin rash, headache, nausea, vomiting, digestive upset, diarrhea, and restlessness. These are often transient and self-limiting. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until you understand the medication's effects on you. Alcohol consumption should be avoided due to potential increased drowsiness. Prior to commencing treatment, disclose any existing kidney or liver conditions to your doctor for appropriate dosage adjustment. Similarly, inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Asmaphylin M 231mg/69mg/10mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Asmaphylin M 231mg/69mg/10mg Tablet SR
Managing Asthma
Major Benefits of Asmaphylin M 231mg/69mg/10mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Asmaphylin M 231mg/69mg/10mg sustained-release tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Asmaphylin M 231mg/69mg/10mg Tablet SR:
- Skin rash
- Headache
- Nausea
- Vomiting
- Upset stomach
- Diarrhea
- Restlessness
- Flu-like symptoms
How to use Asmaphylin M 231mg/69mg/10mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing. Asmaphylin M 231mg/69mg/10mg Extended-Release Tablets should be administered on an empty stomach.
How Asmaphylin M 231mg/69mg/10mg Tablet SR works:
Asmaphylin M SR tablets (231mg/69mg/10mg) contain etofylline, theophylline, and montelukast. Etofylline and theophylline, both bronchodilators, ease airway muscle constriction, improving airflow. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, a chemical that triggers inflammation. This dual mechanism combats airway and nasal inflammation, offering both asthma prevention and allergy symptom relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Asmaphylin M 231mg/69mg/10mg SR Tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Asmaphylin M 231mg/69mg/10mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Prolonged-release Asmaphylin M tablets (231mg/69mg/10mg) are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Taking Asmaphylin M 231mg/69mg/10mg SR tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Asmaphylin M 231mg/69mg/10mg SR tablets in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Asmaphylin M 231mg/69mg/10mg Tablet SR. Dosage modification of Asmaphylin M 231mg/69mg/10mg Tablet SR might be necessary. Physician consultation is recommended.
What if you forget to take Asmaphylin M 231mg/69mg/10mg Tablet SR :
Should you forget a dose of Asmaphylin M 231mg/69mg/10mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Asmaphylin M 231mg/69mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Breathing |
